Literature DB >> 8955228

Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients.

M Vavassori1, R Maccario, A Moretta, P Comoli, A Wack, F Locatelli, A Lanzavecchia, E Maserati, P Dellabona, G Casorati, D Montagna.   

Abstract

We investigated the contribution of transfer of Ag-experienced donor T cells to the immune reconstitution of allogeneic bone marrow transplantation (BMT) recipients. To this purpose, we used a combination of cell culture methods to isolate tetanus toxoid (TT)-specific T cell clones, and a sensitive and specific heteroduplex analysis to monitor the presence of a particular clonotype using TCR N region sequences. We document that patients after BMT display a small response to TT, entirely accounted for by few donor-derived clones. These patients show a strong polyclonal response to TT vaccination; however, the T cell clones transferred with the transplant can still be detected within the polyclonal T cell lines for up to at least 5 yr after BMT. We also demonstrate that vaccination of donors with TT before BMT results in a more relevant transfer of Ag-experienced T cells, allowing the recipients to mount a strong polyclonal response without need of vaccination. These findings provide a rationale for vaccinating donors to optimize adoptive transfer of protective T cell immunity into recipients, and suggest the possibility of using preventive T cell adoptive therapy in conjunction with marrow infusion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955228

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation.

Authors:  Katayoun Rezvani; A John Barrett
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

2.  Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls.

Authors:  M A Avanzini; A M Carrà; R Maccario; M Zecca; G Zecca; A Pession; P Comoli; M Bozzola; A Prete; R Esposito; F Bonetti; F Locatelli
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

3.  An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinoma.

Authors:  Glenda Canderan; Paola Gruarin; Daniela Montagna; Raffaella Fontana; Gabriele Campi; Giulio Melloni; Catia Traversari; Paolo Dellabona; Giulia Casorati
Journal:  PLoS One       Date:  2010-08-09       Impact factor: 3.240

4.  Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation.

Authors:  Jan Storek; Zhao Zhao; Yiping Liu; Richard Nash; Peter McSweeney; David G Maloney
Journal:  Biol Blood Marrow Transplant       Date:  2008-12       Impact factor: 5.742

5.  Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease.

Authors:  Hong Zheng; Catherine Matte-Martone; Hongmei Li; Britt E Anderson; Srividhya Venketesan; Hung Sheng Tan; Dhanpat Jain; Jennifer McNiff; Warren D Shlomchik
Journal:  Blood       Date:  2007-11-28       Impact factor: 22.113

Review 6.  Immune deficits in allogeneic hematopoietic stem cell transplant (HSCT) recipients.

Authors:  Muhammad A Mir; Minoo Battiwalla
Journal:  Mycopathologia       Date:  2009-01-21       Impact factor: 2.574

7.  Memory T-cell competition for bone marrow seeding.

Authors:  Francesca Di Rosa; Angela Santoni
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

Review 8.  Bone Marrow T Cells and the Integrated Functions of Recirculating and Tissue-Resident Memory T Cells.

Authors:  Francesca Di Rosa; Thomas Gebhardt
Journal:  Front Immunol       Date:  2016-02-16       Impact factor: 7.561

9.  Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantation.

Authors:  J Nilsson; I Granrot; J Mattsson; B Omazic; M Uhlin; S Thunberg
Journal:  Vox Sang       Date:  2017-05-02       Impact factor: 2.144

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.